This is a positive change from Gilead Sciences’s previous quarterly dividend of $0.68. Future dividends will be subject to Board approval. Data is currently not available. Some content on this site is not intended for people outside the United States. The company raised its quarterly dividend by 4.4% to $0.71 per share, … Ex-Div. Subscribe to Dividend.com and have complete access to our exclusive dividend increases list here. FOSTER CITY, Calif.--(BUSINESS WIRE)-- FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.68 per share of common stock for the fourth quarter of 2020. Learn from industry thought leaders and expert market participants. Gilead Sciences Inc. (GILD) is a biopharmaceutical company focused on developing treatments for HIV, viral hepatitis, and cancer with operations in 35 countries worldwide. Because of the possibility of human or mechanical error by Mergent's sources, Mergent or others, Mergent does not guarantee the accuracy, adequacy, completeness, timeliness or availability or for the results obtained from the use of such information. Gilead Sciences's next dividend payment date is on 2021-03-30, when Gilead Sciences shareholders who owned GILD shares before 2021-03-12 will receive a dividend payment of $0.71 per share. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. Gilead Sciences’s dividend payout ratio (DPR) is 44.30%. Date Details; 3/12/2021: $0.71: Quarter: 4.5% +4.4%: 2/4/2021: 3/15/2021: 3/30/2021: Details: 12/14/2020 However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. For the latest updates on our ongoing response to COVID-19, please, Clinical Trials Transparency & Data Sharing Policy, Gilead Announces Plans for New Location in North Carolina’s Research Triangle Region Dedicated to Business Services, Gilead Sciences Statement on the Passing of the Honorable George P. Shultz, PhD. All stock quotes on this website should be considered as having a 24-hour delay. $61.40. Portfolio management news, reports, video and more. Certain financial information included in Dividend.com is proprietary to Mergent, Inc. ("Mergent") Copyright © 2014. Knowing your investable assets will help us build and prioritize features that will suit your investment needs. Dividend stocks making payouts in the next 10 business days and have a history of rebounding in price shortly thereater. Make short-term dividend income. Historical dividend payout and yield for Gilead Sciences (GILD) since 2017. The company has grown its dividend for the last 1 consecutive years and is increasing its dividend by an average of 9.35% each year. One reason is the likely success of Trodelvy in Phase 3 trials. https://www.dividend.com/p/94t4bn80wfcg/1TvHCS6nClaoiVcOKWCLJO/?t=D0notenterM1tremed1a. Browse our guide to explore. The current TTM dividend payout for Gilead Sciences (GILD) as of March 05, 2021 is $2.72 . Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Congratulations on personalizing your experience. This is the 6th consecutive annual increase in the dividend paid by Gilead Sciences, Inc. Gilead Sciences, Inc. is a research‐based biopharmaceutical company that discovers, develops and It has been approved for temporary use as a COVID-19 treatment in nearly 50 countries. The company raised its quarterly dividend by 4.4% to $0.71 per share, which represents a 4.4% forward yield. About Gilead Sciences. Reproduction of such information in any form is prohibited. The increase will result in a quarterly dividend of $0.71 per share of common stock. Gilead Sciences, Inc, a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. Gilead Sciences to Present Results From Phase 2/3 Study of Remdesivir in Children With COVID-19 MT Newswires 03/02 17:36 ET Gilead to Present New Data at CROI 2021 Demonstrating the Company's Commitment to Addressing Urgent Global Health Needs A cash dividend payment of $0.71 per share is scheduled to be paid on March 30, 2021. Add GILD to your watchlist to be reminded of GILD 's next dividend payment. Retirement news, reports, video and more. Critical Facts You Need to Know About Preferred Stocks, Earn More With Dividend Stocks Than With Annuities for Your Retirement, Gilead Sciences Raises Dividend 4% Ahead of ‘Pivotal Pipeline Year’. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead Sciences, Inc. (GILD) will begin trading ex-dividend on March 12, 2021. Find out how much your money can grow by using our Compounding Returns Calculator. Gilead Sciences Announces 4.4 Percent Increase in First Quarter 2021 Dividend FOSTER CITY, Calif.-- (BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 4.4% in the company’s quarterly cash dividend, beginning in the first quarter of 2021. One reason is the likely success of Trodelvy in Phase 3 trials. Analysts, including Matthew Harrison from Morgan Stanley, remain optimistic about the prospects of Gilead’s product pipeline in 2021. Which type of investor describes you best? Great payout. The dividend is currently $0.71 per quarter, so whether compared to the GAAP or non-GAAP Q4 numbers, clearly it is well-covered by earnings. The company’s therapeutics are sold primarily in the United States (92% of product sales) with 68% of its total worldwide revenue coming from three large wholesalers, AmerisourceBergen Corporation, Cardinal Health Inc., and McKesson Corporation. The dividend is payable on March 30, 2021, to stockholders of record at the close of business on March 15, 2021. Analysts, including Matthew Harrison from Morgan Stanley, remain optimistic about the prospects of Gilead’s product pipeline in 2021. The ex-dividend date is Friday, March 12th. Future dividends will be subject to Board approval. Gilead Sciences pays an annual dividend of $2.72 per share, with a dividend yield of 4.21%. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Helpful articles on different dividend investing options and how to best save, invest, and spend your hard-earned money. Not sure where to start? Gilead Sciences Statement on Recent Events in Washington, D.C. Gilead Announces New Arm of HIV Women’s Prevention Study to Evaluate the Investigational Long-Acting HIV-1 Capsid Inhibitor Lenacapavir in Addition to Descovy for PrEP®, Gilead Sciences Statement on The World Health Organization’s Updated Veklury® (Remdesivir) COVID-19 Treatment Guidelines, https://www.businesswire.com/news/home/20210204006013/en/. The yield at … Hand picked by analysts based on Dividend.com rating system. Municipal bonds news, reports, video and more. Dividends are common dividends paid per share, … -1.39 (-2.21%) DATA AS OF Feb 26, 2021. Our premium tools have … Gilead Sciences California-based Gilead Sciences currently pays its shareholders a quarterly dividend of $0.68 per share. Stay up to date with timely dividend news. This represents a $2.84 dividend on an annualized basis and a yield of 4.59%. © 1996-2021 Gilead Sciences, Inc. All rights reserved. https://www.businesswire.com/news/home/20210204006013/en/. In the same quarter last year, Gilead Sciences's earnings per share (EPS) was $2.12. Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.68 per share of common stock for the second quarter of 2020. The company generated 69% of its revenue from HIV products, 8% of its revenue from Hepatitis C virus (HCV) related products, 11% of its revenue from Veklury, and 10% from other product sales during 2020. Since 2016, Gilead's trailing-12-month dividend payout has increased from $1.56 per share to $2.63 per share, giving the dividend a … For the latest updates on our ongoing response to COVID-19, please click here. GILD Dividends. The increase will result in a quarterly dividend of $0.71 per share of common stock. FOSTER CITY, Calif.-- (BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 4.4% in the company’s … Gilead Sciences, Inc. has its next earnings report out between April 28 and May 03, 2021. The dividend is payable on March 30, 2021, to stockholders of record at the close of business on March 15, 2021. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000. Date Rec. Want to keep track of all the dividend increases? This is […] Gilead Sciences, Inc. (NASDAQ:GILD) announced a quarterly dividend on Thursday, February 4th, RTT News reports. Gilead Sciences reported fourth quarter revenue that rose 26% to $7.3 billion, beating consensus estimates by $130 million, and non-GAAP earnings of $2.19 per share, beating consensus estimates by four cents. GILD's next quarterly dividend payment will be made to shareholders of record on Tuesday, March 30. The ex-dividend date is Friday, March 12th. GILD Dividend History & Description — Gilead Sciences Inc. Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 4.4% in the company’s quarterly cash dividend, beginning in the first quarter of 2021. The cash dividend will be paid on March 30, 2021 to holders of record as of March 15, 2021. Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 4.4% in the company’s quarterly cash dividend, beginning in the … The dividend is payable on March 30, 2021 to shareholders on record as of March 15, 2021. Dividend Definition. Higher Veklury and HIV product sales offset weakness in Truvada-based products following the loss of exclusivity and lower HCV sales due to fewer patient starts during the COVID-19 pandemic. Tuesday, February 9, 2021 Dividend Increase #16 of 2021 - Gilead Sciences, Inc. (GILD) Thursday, February 4th the Board of Directors of Gilead Sciences, Inc. (GILD) announced a quarterly dividend increase of from $ 0.68 to $ 0.71 per share that’s payable March 30, 2021 to … The current dividend yield for Gilead Sciences as of March 05, 2021 is 4.21% . On Feb 02, 2021, Gilead Sciences (NASDAQ: GILD) reported Q4 2020 earnings per share (EPS) of $1.24, up 41.51% year over year. Investors of record on Monday, March 15th will be paid a dividend of 0.71 per share by the biopharmaceutical company on Tuesday, March 30th. The dividend is payable on March 30, 2021, to stockholders of record at the close of business on March 15, 2021. Gilead Sciences has a number of strong milestones coming in 2021. Date Amount Type Yield Change Decl. Gilead Sciences's dividend payout ratio is 44.30%. Future dividends will be subject to Board approval. About Gilead Sciences. March 9, 2021 Gilead’s Investigational Lenacapavir Demonstrates Sustained Long-Acting Efficacy Through Week 26 in Data Presented at CROI; March 6, 2021 Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults in Four-Year Data Presented at CROI; March 5, 2021 Gilead Sciences, Inc. Common Stock (GILD) Gilead Sciences, Inc. Common Stock. Especially the company's Oncology business which has the potential to be almost half of the company's revenue by 2030. In trading on Monday, shares of Gilead Sciences entered into oversold territory, hitting an RSI reading of 29.95, after changing hands as low as $56.83 per share. About Gilead Sciences Revenue growth was primarily driven by $1.9 billion in Veklury sales during the quarter while management continued to build out its pipeline. Knowing your AUM will help us build and prioritize features that will suit your management needs. For a full year, that's … Fixed income news, reports, video and more. Please help us personalize your experience. This represents a $2.84 dividend on an annualized basis and a yield of 4.31%. Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 4.4% in the company’s quarterly cash dividend, beginning in … 1. There are several well known large cap stocks going ex-dividend next week including the following nine stocks: Traveler’s, Ameren, Kraft Heinz, Eastman Chemical, Viacom, Coca-Cola, Gilead Sciences, Merck and Digital Realty Trust. Gilead Sciences Profile Date Pay. Veklury has been in demand as its antiviral properties have shown promise in treating emerging viral pathogens, including ebola, SARS, and SARS-CoV-2, the virus that causes COVID-19. 30 Dec 2020 (Wed) 30 Mar 2021 (Tue) Forecast Accuracy. View source version on businesswire.com: Build conviction from in-depth coverage of the best dividend stocks. 98%. (GILD) Nasdaq Listed. Total Gilead Sciences earnings for the quarter were $1.55 billion. Practice management news, reports, video and more. Nasdaq 100. Monthly payments from Quarterly Payers ››. FOSTER CITY, Calif. -- (BUSINESS WIRE)--Feb. 4, 2021-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 4.4% in the company’s quarterly cash dividend, beginning in the first quarter of 2021. * Dividend.com does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. What is the value of your investable assets? Gilead Sciences raises dividend 10.5% to $0.63 quarterly: 2018-02-06: GILD: Gilead Sciences raises dividend 9.6% to $0.57 quarterly: 2017-02-08: GILD: Gilead Sciences raises dividend 10.5% to $0.52 quarterly: 2016-04-28: GILD: Gilead raises dividend 9.3% to $0.47 quarterly